Vistagen Therapeutics, Inc. (VTGN)

0.6405 +0.01 (+0.99%) USD  |  NASDAQ  |  Jan 22, 09:35
More

Vistagen Therapeutics Amortization Expense CF (Quarterly)

Amortization Expense CF (Quarterly) Chart

View Amortization Expense CF (Quarterly) for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (Quarterly) Range, Past 5 Years

View Amortization Expense CF (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (Quarterly) Benchmarks

View Amortization Expense CF (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Omeros Corp. --
GeoVax Labs, Inc. --
Daré Bioscience, Inc. --